Cytosorbents Corporation is a leader in blood purification technology, specializing in developing innovative therapies to treat life-threatening conditions. Founded in 1997, the company has revolutionized critical care medicine with its flagship product, CytoSorb, a unique blood purification technology designed to reduce cytokine storm and inflammation in critically ill patients. Cytosorbents is dedicated to improving patient outcomes and transforming the standard of care in critical care medicine and beyond.

Refer new talent to Cytosorbents